Professional Documents
Culture Documents
Flavins are useful in physiologic systems in that they are stronger oxidizing
agents than NAD+, thus fitting in further along the electron transport chain.
They participate in one or two electron processes (and thus reactions with
free radicals or metal ions), and in reduced form react directly with O (as in
hydroxylation reactions). Riboflavin is thus an enzyme cofactor, or
coenzyme, fundamental to many areas of metabolism, and is intimately
involved in processes by which the oxidation of glucose and fatty acids are
utilized for adenosine triphosphate (ATP) formation, and thus the support of
metabolic processes. Riboflavin coenzyme formation (and thus trapping
within cells), is initiated through phosphorylation by a flavokinase, which is
positively regulated by the most active form of thyroid hormone.
Flavins that are bound to proteins are resistant to degradation. However,
unbound forms are subject to catabolism. Both FAD and FMN are
catabolized by intracellular enzymes in ways directly analogous to the
breakdown of these forms in foods during their absorption across the
intestinal mucosal cell. Thus, FAD is converted to FMN by FAD-
pyrophosphatase (releasing AMP), and FMN is degraded to free riboflavin by
FMN-phosphatases. Both FAD and FMN are split to yield free riboflavin by
alkaline phosphatase.
The degradation of riboflavin per se involves initially its hydroxylation at
the 7α- and 8α-positions of the isoalloxazine ring by hepatic microsomal
cytochrome P-450-dependent processes. It is thought that catabolism
proceeds by the oxidation and then removal of the methyl groups. The liver,
in at least some species, has the ability to form riboflavin α-glycosides. As a
result of this metabolism, human blood plasma contains FAD and FMN as
the major riboflavin metabolites, as well as small amounts of 7α-
hydroxyriboflavin. Side chain oxidation has been observed in bacterial
systems, but not in higher animals.